Oxygene Medical Liquide Vivisol (Oxygen)

Oxygene Medical Liquide Vivisol is a medical gas used in respiratory support pathways.

• Acute hypoxemic respiratory failure: improves oxygenation and reduces work of breathing.
• Chronic obstructive pulmonary disease (COPD) exacerbations: provides supplemental oxygen to maintain target saturations.
• Peri‑operative care: maintains adequate oxygen levels during anesthesia and postoperative recovery.
• Home oxygen therapy for chronic hypoxaemia: delivers prescribed oxygen concentrations for long‑term use.
• Neonatal respiratory distress: supplies oxygen to preterm infants requiring respiratory support.

• Oxygen delivered as a liquid inhalation gas diffuses across the alveolar membrane into the pulmonary capillary blood, raising arterial partial pressure of oxygen (PaO₂). The increased PaO₂ enhances hemoglobin saturation, improving tissue oxygen delivery and supporting cellular metabolism in hypoxic conditions.

Oxygen therapy may be associated with a range of adverse reactions, most of which are related to delivery method or concentration.

Common Side Effects

• Dry or irritated nasal passages.
• Cough or mild throat irritation.
• Headache due to hyperoxia.
• Light‑headed dizziness when flow rates are high.
• Skin irritation at cannula or mask contact points.

Serious or Rare Side Effects

• Pulmonary oxygen toxicity leading to atelectasis or fibrosis.
• Retinopathy of prematurity in preterm infants.
• Fire hazard when high‑flow oxygen contacts ignition sources.
• Hypercapnia in patients with chronic CO₂ retention.
• Severe bronchospasm in susceptible individuals.

When using Oxygene Medical Liquide Vivisol, clinicians should observe several safety measures.

• Patient assessment: verify indication and baseline oxygen saturation before initiation.
• Flow rate titration: adjust to maintain target SpO₂ while avoiding excessive FiO₂.
• Monitoring: continuous pulse oximetry and periodic arterial blood gases are recommended.
• Contraindications: avoid in patients with known oxygen sensitivity or untreated pneumothorax.
• Fire safety: keep away from open flames, smoking materials, and static electricity sources.
• Store at ambient temperature: keep container in original packaging, protect from direct sunlight and extreme temperatures.

Oxygen can influence the efficacy or safety of several concomitant therapies.

Major Interactions (Avoid)

• Nitric oxide therapy: concurrent high‑flow oxygen may reduce vasodilatory effect.
• Para‑aminosalicylic acid: increased risk of oxidative hemolysis.

Moderate Interactions (Monitor Closely)

• Sedatives and opioids: enhanced respiratory depression risk; monitor ventilation.
• Inhaled bronchodilators: may require adjustment of oxygen flow to prevent hyperoxia.
• Chemotherapy agents (e.g., bleomycin): oxygen can potentiate pulmonary toxicity.
• Antioxidant supplements: theoretical reduction in oxygen‑related oxidative stress; clinical relevance unclear.